5:49 PM
 | 
Nov 10, 2009
 |  BC Extra  |  Top Story

Regeneron, sanofi-aventis expand deal

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and sanofi-aventis Group (Euronext:SAN; NYSE:SNY) extended by five years a 2007 deal to discover, develop and commercialize human antibodies using Regeneron's VelociSuite technologies. Beginning in 2010, sanofi-aventis will increase its...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >